ABCP earnings analysis
What we found in ABCP's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q extract does not include the condensed statements of operations, balance sheets, cash flows, or MD&A, so revenue, margins, EPS, cash flow, balance-sheet trends, and segment performance cannot be quantified. The filing states that there were no material changes to previously disclosed risk factors and reports 0 year-to-date 2026 repurchases under a 10 million-share authorization. Continued disclosure of litigation funding agreements and the absence of quantitative guidance leave litigation, liquidity, and financing uncertainty as the primary signals.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- No Year-to-Date Share Repurchases
- The company’s repurchase plan authorizes purchases of up to 10 million common shares, but no shares were repurchased year to date in 2026.
- Litigation Funding Agreements Disclosed
- The filing includes 2 litigation funding agreements as exhibits: one with Richard A. Bianco and one with BARC Investments LLC.
- Quarterly Filing Completed
- The filing was signed on August 12, 2026, for the quarter ended June 30, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- No Capital Return Activity
- The company reported 0 shares repurchased under its 10 million-share repurchase authorization during year-to-date 2026, indicating no evidence of capital return in the period.
- Existing Risks Remain Unchanged
- Item 1A states there were no material changes to the risk factors disclosed in the 2025 Form 10-K; therefore, the filing does not reduce previously disclosed risks, including litigation and liquidity concerns.
- Continued Litigation Financing Dependence
- The filing identifies 2 litigation funding agreements and includes a July 31, 2026 letter agreement as an exhibit, underscoring continued reliance on litigation-related financing arrangements.
What they said about what is next.
No quantitative revenue or EPS outlook is provided in the supplied 10-Q extract; the filing does not establish guidance.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 11, 2026
- AmBase Corporation's Q1 2026 results show a reduced net loss of $775,000 ($0.01 per share), improving from a net loss of $1,592,000 ($0.02 per share) in Q1 2025. Management continues to highlight substantial doubts…
- 10-K · March 30, 2026
- AmBase is a small holding company whose December 31, 2025 assets are described as consisting “primarily of cash and cash equivalents,” with historic exposure to a disputed equity interest in the 111 West 57th Street…
- 10-Q · November 6, 2025
- AmBase reported no revenue and a narrower Q3 2025 net loss of $(1,091) (basic EPS $(0.01)) versus a Q3 2024 loss of $(1,533) (EPS $(0.02)). Operating expenses continued to decline — $985 in Q3 2025 versus $1,523 in Q3…
- 10-Q · August 13, 2025
- AmBase reported no revenue and a Q2 2025 net loss of $(1,083) (three months), with basic EPS of $(0.01), versus a Q2 2024 net loss of $(1,935) and EPS $(0.02). Operating expenses and operating loss narrowed…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing ABCP makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever